Home・Aktien・Progyny Inc

Progyny Inc

Geschlossen

BrancheGesundheitswesen

25.95 2.21

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

25.39

Max

26.52

Schlüsselkennzahlen
By Trading Economics
Einkommen	28M 52M
Verkäufe	22M 351M
KGV Branchendurchschnitt	28.461 57.371
EPS	0.34
Gewinnspanne	14.917
Angestellte	835
EBITDA	5.9M 44M

Empfehlungen
By TipRanks
Empfehlungen	Starkes Kaufsignal
12-Monats-Prognose	+33.18% upside

Dividenden
By Acuity
Nächstes Ergebnis	5. Nov. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-495M 1.9B
Vorheriger Eröffnungskurs	23.74
Vorheriger Schlusskurs	25.95

Nachrichtenstimmung

By Acuity

93%

6 / 340 Ranking in Healthcare

Progyny Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

18. Aug. 2026, 20:06 UTC

Progyny Inc. shares are higher today, reflecting steady gains during the session. The stock remains below its 20-day moving average.

17. Aug. 2026, 20:01 UTC

News

Progyny Inc shares are lower following a negative market reaction to its second-quarter earnings and lowered full-year revenue guidance to $1.37 billion.

14. Aug. 2026, 20:06 UTC

Progyny Inc shares are higher during Friday's session, despite a recent pullback from earlier highs. Broader market sentiment remains mixed amid declining U.S. retail sales.

13. Aug. 2026, 21:31 UTC

Progyny Inc shares are higher in after-market trading, recovering from earlier losses. No specific news was identified to explain the price movement.

12. Aug. 2026, 20:01 UTC

News

Progyny Inc shares are lower following a Barclays downgrade, which cut the price target to $30 from $34, citing performance concerns.

11. Aug. 2026, 20:02 UTC

News

Progyny Inc's stock is declining after a disappointing revenue forecast, despite strong second-quarter results that exceeded analyst expectations.

7. Aug. 2026, 20:02 UTC

News

Progyny Inc's shares are lower after a cautious Q3 sales outlook, despite reporting revenue of $350.5 million that exceeded analyst expectations.

6. Aug. 2026, 23:02 UTC

News

Progyny Inc shares are lower in after-market trading following a revenue guidance cut to $1.36 billion to $1.39 billion, below previous estimates.

31. Juli 2026, 19:46 UTC

Progyny Inc shares are lower today amid broader market pressures and rising bond yields. No specific company news was identified to explain the decline.

30. Juli 2026, 21:02 UTC

Progyny Inc shares are lower in after-market hours, with no specific news identified for the decline. The stock is below its 20-day moving average.

29. Juli 2026, 18:55 UTC

Progyny Inc shares are higher today, reflecting notable strength in trading. The stock remains above its 20-day moving average.

28. Juli 2026, 17:41 UTC

News

Social Media

Progyny Inc shares are lower following a downgrade by Barclays, which noted slowing website traffic growth at fertility clinics. Price target raised to $34 from $27.

24. Juli 2026, 15:06 UTC

News

BTIG maintained its Buy rating on Progyny and raised the price target to $40. Shares are trading higher, remaining above the 20-day moving average.

22. Juli 2026, 20:01 UTC

News

Progyny Inc shares are lower despite the acceptance of benefits at Pinnacle Fertility New York, enhancing access to reproductive care for members.

20. Juli 2026, 17:16 UTC

Progyny Inc shares are higher today, maintaining a position near their one-month trading range. No specific news was identified to explain the movement.

Peer-Vergleich

Kursveränderung

Progyny Inc Prognose

Kursziel

By TipRanks

33.18% Vorteil

12-Monats-Prognose

Durchschnitt 34 USD 33.18%

Hoch 40 USD

Tief 27 USD

Basierend auf 10 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Progyny Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

10 ratings

Buy

Halten

Sell

Basierend auf 10 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Progyny Inc – Dist abgegeben haben.

Stimmung

By Acuity

6 / 340 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Progyny Inc

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.